Growth Metrics

Addex Therapeutics (ADXN) Return on Assets (2022 - 2025)

Historic Return on Assets for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to 0.16%.

  • Addex Therapeutics' Return on Assets fell 4300.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 4300.0%. This contributed to the annual value of 1.57% for FY2024, which is 28700.0% up from last year.
  • Per Addex Therapeutics' latest filing, its Return on Assets stood at 0.16% for Q3 2025, which was down 4300.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Addex Therapeutics' Return on Assets ranged from a high of 1.25% in Q1 2025 and a low of 3.61% during Q1 2024
  • For the 4-year period, Addex Therapeutics' Return on Assets averaged around 0.5%, with its median value being 0.15% (2025).
  • In the last 5 years, Addex Therapeutics' Return on Assets crashed by -27100bps in 2024 and then skyrocketed by 48600bps in 2025.
  • Over the past 4 years, Addex Therapeutics' Return on Assets (Quarter) stood at 1.08% in 2022, then plummeted by -141bps to 2.6% in 2023, then skyrocketed by 139bps to 1.0% in 2024, then crashed by -116bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q3 2025, 0.15% for Q2 2025, and 1.25% during Q1 2025.